Uso de medicamentos por gestantes: uma revisão.

Abstract

The thalidomide tragedy in the early 1960s marked the lives of many families, including contributing to a reflection on the use of medications during pregnancy and the importance of pre-clinical trials. However, the provisions in pregnancy only increase and this medical practice needs to be reviewed to avoid major hassles for pregnant women and fetus. The objective of this study was to make a literature review on the use of medication during pregnancy, featuring the most used drug classes and classification according to the risk posed. For this, a survey was conducted of the studies published in Brazil for the period from 2004 to 2014. The survey was conducted with Scielo and BVS database with keywords: EUM, drug use and pregnancy. The results showed that the Basic Health Units are the main site of care among pregnant women, probably due to socioeconomic and cultural factors that affect the public. Women with incomplete primary education, low income and the average age 25-66 years were the most cited in the studies and the most widely used pharmacological group were antianemics, with ferrous sulfate increased use of drug, being major cause of iron supplement indicated in cases of anemia diagnosed during pregnancy. Regarding the most frequently cited risk rating was the risk category A, which are drugs free of risk to the fetus and the diseases that most affect the pregnancy are chronic diseases, with greater use of medicines made in the first quarter. So it observed the need for analytical studies intended to investigate the factors associated with use of drugs, for health professionals and pregnant women obtain further information and thus enable the use of rationally medication during pregnancy.